Gundersen Regional Clinics Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 1830 State Highway 9 Ste 100, Decorah, IA 52101 Phone: 608-782-7300 |
Winnmed Mabel Clinic Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 |
Family Care Clinic Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 903 Commerce Dr, Decorah, IA 52101 Phone: 563-382-1200 Fax: 563-382-1211 |
Gundersen Nonaco Clinic/Center Medicare: Medicare Enrolled Practice Location: 1830 State Highway 9 Ste 100, Decorah, IA 52101 Phone: 608-782-7300 |
Winnmed Luther Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 College Drive, Larsen Building-ll, Decorah, IA 52101 Phone: 563-387-1045 Fax: 563-387-1053 |
The Family Care Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 911 S Mill St, Decorah, IA 52101 Phone: 563-382-1200 Fax: 563-382-1211 |
Gl Decorah Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1830 State Highway 9, Decorah, IA 52101 Phone: 608-782-7300 |
Winnmed Decorah Clinic Clinic/Center - Multi-Specialty Medicare: Medicare Enrolled Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 Fax: 563-387-3102 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyCell CHO cell-culture medium, a versatile animal-derived- component-free (ADCF) and chemically defined (CD) medium for culturing a broad variety of CHO cells.
Most U.S. homes are full of familiar household products with an ingredient that fights bacteria: triclosan. Triclosan seems to be everywhere. When we wash our hands, brush our teeth, or do our laundry, we are likely putting triclosan into our water sources.
Cervical Cancer is a tragic disease. First and foremost, because it is entirely preventable if the early symptoms are detected in a timely manner
BIOTRONIK, a leading manufacturer of innovative medical technology, has received FDA approval of its new Lumax 740 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds). Lumax 740 helps physicians monitor and treat their patients' arrhythmias and heart failure under ever-changing medical conditions.
In a study of 142 patients preparing for cancer surgery, Johns Hopkins Medicine researchers say they have evidence that psychological or social risk factors such as depression, limited resilience and lack of emergency resources along with standard medical risk factors such as high blood pressure or diabetes are linked with higher risks of surgical complications.
› Verified 8 days ago